Skip to main content Skip to footer site map
  • DONATE

NJ Spotlight News | Clip | Merck discontinues COVID-19 vaccine development

Kenilworth-based Merck says it will discontinue development of its two COVID-19 vaccine candidates after a review of early clinical studies found that they produced insufficient immune responses. Merck was late to the game in the effort to develop coronavirus vaccines and instead has been focusing on coronavirus treatments.

0:02:42 | AIRED: 1/25/2021 |
THIRTEEN Passport | A benefit of membership | Activate Now
Membership Promo

NEWSLETTER SIGNUP

CONNECT WITH THIRTEEN